Pneumology
The findings suggest that the interplay between the respiratory tract microbiota, the levels of bacterial pathogens and specific clinical interventions is a key factor in determining the outcome of bacterial…
Airway dysbiosis was associated with a lung function decline in COPD patients and it might contribute to this phenotype through metabolic interaction with host pathophysiological processes.
A supplement of LGG would seem to favour the proliferation of Bifidobacterium and the improvement of clinical and immunological response to childhood cystic fibrosis.
COVID-19 alters the local immunity of the lung in ways that weaken the body’s antimicrobial defense and facilitate the development of secondary infections.
The findings of a new research suggest that changes in the microbial composition of people with COVID-19 could be used as a biomarker of invasion of lung pathogens and dysbiosis…
New research investigates the role of lung microbiota in pediatric patients with lung infection or injury after bone marrow transplantation.
Early viral encounters are associated with disadvantageous immune and microbiota profiles, as well as recurrent respiratory infections. A new study published in Nature Microbiology claims.
Profiling the bacteria and viruses residing in the human body could help to diagnose different pathogens and develop new targeted interventions.
Targeted manipulation to promote the microbial diversity could be an important strategy to treat long COVID-19 and speed up recovery.
The Integrative Microbiomics tool could potentially delineate subtypes of bronchiectasis and other heterogeneous respiratory diseases.
